Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup

NCT05142462 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2024-02-20

No results posted yet for this study

Summary

EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery.

Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.

As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety

Conditions

  • Hip Arthropathy
  • Hip Osteoarthritis
  • Hip Necrosis
  • Hip Fractures
  • Hip Dysplasia
  • Hip Arthritis

Interventions

DEVICE

Hip arthroplasty

Hip prosthesis surgical implantation

Sponsors & Collaborators

  • EUROS

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-27
Primary Completion
2022-07-29
Completion
2032-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05142462 on ClinicalTrials.gov